- Investing Ideas
- /
- Belgian Pharmaceuticals & Biotech Big Green Snowflakes
Belgian Pharmaceuticals & Biotech Big Green Snowflakes
Results
8
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
8 companies
argenx
Market Cap: €37.5b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€613.20
7D
-2.9%
1Y
26.3%
UCB
Market Cap: €37.4b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€196.90
7D
-4.6%
1Y
21.5%
Hyloris Pharmaceuticals
Market Cap: €163.5m
Engages in the research, development, and manufacture of pharmaceutical products to address medical needs.
HYL
€5.84
7D
-2.7%
1Y
-1.0%
Oxurion
Market Cap: €947.1k
A biopharmaceutical company, develops medicines to prevent blindness in Belgium.
OXUR
€0.019
7D
-14.5%
1Y
-95.2%
Financière de Tubize
Market Cap: €7.1b
Operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium.
TUB
€159.00
7D
-5.4%
1Y
21.2%
European Medical Solutions
Market Cap: €23.3m
Engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium.
ALEMS
€5.50
7D
6.8%
1Y
-21.9%
BioSenic
Market Cap: €1.6m
A biotechnology company, develops cell therapy products and treatments for autoimmune and inflammatory diseases in Belgium and France.
BIOS
€0.0025
7D
4.2%
1Y
-63.8%
Celyad Oncology
Market Cap: €13.8m
A biotechnology company, focuses on the research and development of chimeric antigen receptor T cell (CAR T) therapies for cancer.
CYAD
€0.31
7D
0.7%
1Y
15.1%